Published in
Elsevier, Contemporary Clinical Trials Communications, (16), p. 100409, 2019
DOI: 10.1016/j.conctc.2019.100409
Links
Tools
First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427)
Journal article published in 2019 by
Toan Pham,
Lloyd Pereira,
Sara Roth,
Laura Galletta,
Emma Link,
Tim Akhurst,
Ben Solomon,
Michael Michael,
Phillip Darcy,
Shienny Sampurno,
Alexander Heriot,
Robert Ramsay,
Jayesh Desai 
This paper is made freely available by the publisher.
Full text: Download
Data provided by 